Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.1 | - |
NAV | ₹30.25 | - |
Fund Started | 04 Dec 2015 | - |
Fund Size | ₹1338.85 Cr | - |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹30.25
-
Fund Started
04 Dec 2015
-
Fund Size
₹1338.85 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
Returns
1 Year | 0.10% | - |
3 Year | 21.86% | - |
5 Year | 15.74% | - |
1 Year
0.10%
-
3 Year
21.86%
-
5 Year
15.74%
-
Holding Analysis
Equity | 95.00% | - |
Cash | 5.00% | - |
Equity
95.00%
-
Cash
5.00%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.75% |
Max Healthcare Institute Ltd. | 5.65% |
Healthcare Global Enterprises Ltd. | 5.13% |
Abbott India Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.85% |
Ipca Laboratories Ltd. | 3.99% |
Cipla Ltd. | 3.96% |
Rainbow Children's Medicare Ltd. | 3.78% |
Lupin Ltd. | 3.57% |
Ajanta Pharma Ltd. | 3.45% |
-
Fund Manager
Name | Meeta Shetty | - |
Start Date | 11 Nov 2024 | - |
Name
Meeta Shetty
-
Start Date
11 Nov 2024
-
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | - |
Launch Date | 04 Dec 2015 | - |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-